We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Bloomin' Brands
BLMN
$688M
| $7.57M | 0.02% |
345,163
-97,824
| -22% | -$2.11M |
|
677
Curtiss-Wright
CW
$21.1B
| $7.56M | 0.02% |
50,341
+43,528
| +639% | +$6.19M |
|
678
Nasdaq
NDAQ
$49.6B
| $7.56M | 0.02% |
127,236
+80,850
| +174% | +$4.78M |
|
679
Exelixis
EXEL
$14.1B
| $7.53M | 0.02% |
332,080
+217,714
| +190% | +$4.25M |
|
680
Capri Holdings
CPRI
$1.67B
| $7.45M | 0.02% |
144,914
-14,381
| -9% | -$861K |
|
681
TG Therapeutics
TGTX
$8.55B
| $7.44M | 0.02% |
+782,533
| New | +$9.06M |
|
682
Dick's Sporting Goods
DKS
$11B
| $7.44M | 0.02% |
74,378
+2,526
| +4% | +$278K |
|
683
Boston Scientific
BSX
$63.6B
| $7.44M | 0.02% |
167,944
-26,755
| -14% | -$1.16M |
|
684
ANI Pharmaceuticals
ANIP
$1.69B
| $7.42M | 0.02% |
263,774
-3
| -0% | -$112 |
|
685
KLA
KLAC
$219B
| $7.38M | 0.02% |
201,500
-22,100
| -10% | -$827K |
|
686
Synaptics
SYNA
$3.49B
| $7.33M | 0.02% |
36,758
+28,952
| +371% | +$6.42M |
|
|
SBDS
687
DELISTED
Solo Brands Inc
SBDS
| $7.25M | 0.02% |
21,250
-2,275
| -10% | -$1.01M |
|
688
Paycom
PAYC
$10.3B
| $7.21M | 0.02% |
20,808
+374
| +2% | +$125K |
|
689
Teradata
TDC
$2.71B
| $7.17M | 0.02% |
145,470
+46,687
| +47% | +$2.14M |
|
690
Chegg
CHGG
$81.5M
| $7.15M | 0.02% |
197,110
+70,541
| +56% | +$2.12M |
|
691
C.H. Robinson
CHRW
$17.9B
| $7.15M | 0.02% |
66,383
-38,099
| -36% | -$3.87M |
|
|
CMLS
692
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $7.14M | 0.02% |
717,457
-116,824
| -14% | -$1.24M |
|
693
Evercore
EVR
$10.1B
| $7.1M | 0.02% |
63,800
+86
| +0.1% | +$10.6K |
|
694
SK Telecom
SKM
$13.6B
| $7.1M | 0.02% |
+277,003
| New | +$7.18M |
|
695
TTM Technologies
TTMI
$12B
| $7.07M | 0.02% |
477,309
-35,742
| -7% | -$490K |
|
696
Fluence Energy
FLNC
$1.3B
| $7.07M | 0.02% |
539,300
-512,300
| -49% | -$8.59M |
|
|
ITOS
697
DELISTED
iTeos Therapeutics
ITOS
| $7.06M | 0.02% |
219,272
+123,474
| +129% | +$4.49M |
|
698
Boeing
BA
$160B
| $6.95M | 0.02% |
36,278
+23,181
| +177% | +$4.65M |
|
699
Idacorp
IDA
$7.68B
| $6.94M | 0.02% |
60,194
+10,752
| +22% | +$1.17M |
|
700
Range Resources
RRC
$9.08B
| $6.93M | 0.02% |
228,085
+14,574
| +7% | +$333K |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.